<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00335296</url>
  </required_header>
  <id_info>
    <org_study_id>CA0005/09</org_study_id>
    <nct_id>NCT00335296</nct_id>
  </id_info>
  <brief_title>PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)</brief_title>
  <official_title>The Paradigm IIca/III Trial: PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cierra</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cierra</source>
  <brief_summary>
    <textblock>
      The primary objective of this study is to demonstrate the safety and performance of the PFx
      Closure System when utilized for patients with PFOs suffering from cryptogenic stroke,
      transient ischemic attack, migraine or decompression illness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patent Foramen Ovale has been implicated in the etiology of paradoxical embolism, cryptogenic
      stroke, transient ischemic attack, and right to left gas embolism in severe decompression
      illness. An association between patent foramen ovale and severe migraine headaches has also
      been reported. Several implantable devices are being used for percutaneous closure of patent
      foramen ovale; this study uses a non-implantable system to safely effect closure with the
      application of radiofrequency energy.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PFO closure 6 months post procedure</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PFO closure at 30 days and 12 months post procedure</measure>
    <time_frame>30 days, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AE event rates for all subjects</measure>
    <time_frame>30 days, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migraine severity</measure>
    <time_frame>6 and 12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Patent Foramen Ovale</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PFx catheter</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 65 years old

          -  Documented PFO

          -  Subjects with one or more of the following:cryptogenic stroke, transient ischemic
             attack, embolism, migraine headaches, decompression illness

        Exclusion Criteria:

        â€¢ Inappropriate anatomy (vascular or cardiac) or inappropriate medical condition for PFO
        closure and study medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alec Vahanian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bichat Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Middleheim Hospital</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Hospitalier Jacques Carter</name>
      <address>
        <city>Massy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bichat Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75877</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Center Frankfurt Sankt katharinen</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2006</study_first_submitted>
  <study_first_submitted_qc>June 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2006</study_first_posted>
  <last_update_submitted>December 18, 2007</last_update_submitted>
  <last_update_submitted_qc>December 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2007</last_update_posted>
  <keyword>PFO</keyword>
  <keyword>Migraine</keyword>
  <keyword>Stroke</keyword>
  <keyword>TIA (transient ischemic attack)</keyword>
  <keyword>Decompression Illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Foramen Ovale, Patent</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

